Your browser doesn't support javascript.
loading
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.
Dornbierer, Dario A; Marten, Laurenz; Mueller, Jovin; Aicher, Helena D; Mueller, Michael J; Boxler, Martina; Kometer, Michael; Kosanic, Davor; von Rotz, Robin; Puchkov, Maxim; Kraemer, Thomas; Landolt, Hans-Peter; Seifritz, Erich; Scheidegger, Milan.
Affiliation
  • Dornbierer DA; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
  • Marten L; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Mueller J; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, Zurich, Switzerland.
  • Aicher HD; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, Zurich, Switzerland.
  • Mueller MJ; Department of Chemistry and Applied Biosciences, Zurich, Switzerland.
  • Boxler M; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, Zurich, Switzerland.
  • Kometer M; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, Zurich, Switzerland.
  • Kosanic D; Department of Psychology, University of Zurich, Zurich, Switzerland.
  • von Rotz R; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Puchkov M; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, Zurich, Switzerland.
  • Kraemer T; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Landolt HP; Department of Health Science & Technology, Zurich, Switzerland.
  • Seifritz E; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Scheidegger M; Reconnect Labs, Winterthur, Switzerland.
Front Pharmacol ; 14: 1246892, 2023.
Article de En | MEDLINE | ID: mdl-38089057
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Pharmacol Année: 2023 Type de document: Article Pays d'affiliation: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Pharmacol Année: 2023 Type de document: Article Pays d'affiliation: Suisse